We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PLRX market cap is 691.91M. The company's latest EPS is USD -2.6512 and P/E is -4.29.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -47.69M | -47.04M | -52.39M | -60.64M | -62.01M |
| Net Income | -41.49M | -41.11M | -46.96M | -55.85M | -57.76M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 57.05M | 41.82M | 7.57M | 9.69M | 1.58M |
| Operating Income | -1.23M | -41.65M | -97.54M | -127.2M | -184.15M |
| Net Income | -6.86M | -41.53M | -97.26M | -123.32M | -161.34M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 540.46M | 512.15M | 521.61M | 483.73M | 445.67M |
| Total Liabilities | 37.42M | 38.58M | 84.27M | 91.05M | 99.84M |
| Total Equity | 503.05M | 473.58M | 437.33M | 392.68M | 345.82M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 119.06M | 295.53M | 221.22M | 350.61M | 512.15M |
| Total Liabilities | 9.08M | 12.47M | 22.16M | 37.27M | 38.58M |
| Total Equity | -76.3M | 283.06M | 199.06M | 313.34M | 473.58M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -91.26M | -116.36M | -30.27M | -75.57M | -107.84M |
| Investing | -158.93M | -127.01M | 59.55M | 70.25M | 101.21M |
| Financing | 274.19M | 274.41M | 19.91M | 22.47M | 23.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.75M | -37.27M | -75.44M | -94.63M | -116.36M |
| Investing | -17.93M | -210.87M | 73.7M | -150.2M | -127.01M |
| Financing | 45.54M | 213.21M | 2.53M | 226.85M | 274.41M |
| Market Cap | 691.91M |
| Price to Earnings Ratio | -4.29 |
| Price to Sales Ratio | 437.69 |
| Price to Cash Ratio | 10.95 |
| Price to Book Ratio | 1.46 |
| Dividend Yield | - |
| Shares Outstanding | 60.85M |
| Average Volume (1 week) | 522.79k |
| Average Volume (1 Month) | 495.05k |
| 52 Week Change | -32.20% |
| 52 Week High | 18.00 |
| 52 Week Low | 10.22 |
| Spread (Intraday) | 3.78 (27%) |
| Company Name | Pliant Therapeutics Inc |
| Address |
850 new burton road suite 201 dover, delaware 19904 |
| Website | https://pliantrx.com. |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
